NCT00616564View on ClinicalTrials.gov

Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Malignant Melanoma
Interventions
DRUG

GM-CSF

Concomitant Priming with GM-CSF

Trial Locations (2)

30322

David Lawson, MD, Atlanta

33140

Jose Lutzky, MD, Miami Beach

Sponsors

Collaborators (2)

Bayer
Chiron Corporation
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Chiron Corporation

INDUSTRY

lead

Mt. Sinai Medical Center, Miami

OTHER

NCT00616564 - Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma | Biotech Hunter | Biotech Hunter